Severity of Coronary Artery Disease in Patients of NSTEMI Associated With Elevated Troponin Levels
Saima Zahoor, Sumair Ahmed, Fahad Haider, Kamran Khan, Adeel Ur Rehman, Fiza Sumair
721
ABSTRACT
Non-ST-segment
elevation myocardial infarction (NSTEMI) is more communal than ST-segment
elevation myocardial infarction (STEMI), and statistics on the coexistence of severe
coronary disease among these individuals is consistent across the populace results
in fatal postponement in appropriate treatment.
So, in this study, we tried to assess the
incidence of severe coronary artery disease in NSTEMI where serum levels of troponin
I are significantly elevated. This will benefit
to recognize people who must be categorized as high-risk and refer them to
priority centers for coronary revascularization so that the clinical outcomes
in these patients can be improved.
Study Design: A cross-sectional
study.
Methods: A total of 118
patients with a history of chest complaints for the last 48-hours or symptoms
equivalent to angina. After 72 hours of admission; Coronary angiography was
performed in the same hospital. The result variable; severe coronary artery
disease was labeled.
Results: Of 118 patients, 106
(89.8%) were females, 12 (10.2%) were males, and the M:F ratio was 8.8: 1.
56.05 ± 4.21 years was the mean age of the patients and 30 to 60 years was the
age range. Most of the subjects were 51 and 60 years of age (98=83.1%). In this analysis, 16 (13.6%) patients had
severe CAD, while 102 (86.4%) patients did not have. The mean Troponin-I level
was 7.65±3.07. One vessel was involved in 35(29.7%) of patients, two vessels
were involved in 63(53.4%) of patients and three vessels were involved in
20(16.9%) of patients.
Conclusions: We institute severe coronary
artery disease among significant number of NSTEMI patients. High troponin I
levels are key to detecting the occurrence of severe coronary artery disease among
these patients. Therefore, we concluded that cardiac catheterization should be
performed to detect its presence in all patients with trop-T elevation, even
without ST elevation so that the patients may get advantage from prompt
revascularization, counting coronary artery bypass graft (CABG) surgery. The
severity of coronary artery disease was found in 13.6% of patients with raised
cardiac troponin levels.
Keywords: ST-segment elevation
myocardial infarction (STEMI), non-ST segment elevation acute coronary syndrome
(ACS).
ABSTRACT
Non-ST-segment
elevation myocardial infarction (NSTEMI) is more communal than ST-segment
elevation myocardial infarction (STEMI), and statistics on the coexistence of severe
coronary disease among these individuals is consistent across the populace results
in fatal postponement in appropriate treatment.
So, in this study, we tried to assess the
incidence of severe coronary artery disease in NSTEMI where serum levels of troponin
I are significantly elevated. This will benefit
to recognize people who must be categorized as high-risk and refer them to
priority centers for coronary revascularization so that the clinical outcomes
in these patients can be improved.
Study Design: A cross-sectional
study.
Methods: A total of 118
patients with a history of chest complaints for the last 48-hours or symptoms
equivalent to angina. After 72 hours of admission; Coronary angiography was
performed in the same hospital. The result variable; severe coronary artery
disease was labeled.
Results: Of 118 patients, 106
(89.8%) were females, 12 (10.2%) were males, and the M:F ratio was 8.8: 1.
56.05 ± 4.21 years was the mean age of the patients and 30 to 60 years was the
age range. Most of the subjects were 51 and 60 years of age (98=83.1%). In this analysis, 16 (13.6%) patients had
severe CAD, while 102 (86.4%) patients did not have. The mean Troponin-I level
was 7.65±3.07. One vessel was involved in 35(29.7%) of patients, two vessels
were involved in 63(53.4%) of patients and three vessels were involved in
20(16.9%) of patients.
Conclusions: We institute severe coronary
artery disease among significant number of NSTEMI patients. High troponin I
levels are key to detecting the occurrence of severe coronary artery disease among
these patients. Therefore, we concluded that cardiac catheterization should be
performed to detect its presence in all patients with trop-T elevation, even
without ST elevation so that the patients may get advantage from prompt
revascularization, counting coronary artery bypass graft (CABG) surgery. The
severity of coronary artery disease was found in 13.6% of patients with raised
cardiac troponin levels.
Keywords: ST-segment elevation
myocardial infarction (STEMI), non-ST segment elevation acute coronary syndrome
(ACS).